G-20 Put Global Aging On The Agenda, But Did They Define Longevity As A Problem, Or An Opportunity?

The G-20, the world’s finance ministers and central bankers, are meeting in Japan. In keeping with the backdrop of Japan, the nation with the world’s fastest-aging population, global aging has made its way to the front of G-20’s agenda. Japanese Finance Minister Taro Aso is quoted as warning the world’s financial decision makers that they must act now to take “effective measures against it.”

Those who are invested in making the world a better place for older adults have reason to cheer such a move. The placement of population aging on the G-20’s agenda represents an “historic first” for the international forum. A report published by the Global Coalition on Aging in the lead-up to the meeting targets healthcare, finance, and urban design as three “critical topics” for policymakers—all important spheres for reform and innovation. Digging deeper into the report, one finds lifelong education, age-friendly communities, and improving quality-of-life as opposed to merely extending life being named as priorities—all of which I have myself have argued for in the past.

But the announcement of G-20’s attention to global aging nonetheless has me disappointed. Why? It’s all about the language.

We’ll start with the warning of Taro Aso. “Effective measures” brings to mind dire language in other policy domains, such as that used by public health officials to command action against the flu or a modern epidemic. Elsewhere, in articles in major publications leading up to the forum,we find global aging being spoken of as a “global risk,” something that is “sounding alarms,” a “challenge” to be faced, like a dragon bellowing and crashing at the gates.

While it is difficult to identify when longer life, longevity, became rhetorically synonymous with crisis, it is sad that the G-20 is framing aging in terms of risks alone — ballooning healthcare costs, pensions running bust, and a declining workforce. But, here is the reality, how an issue is socially defined sets the range of possible policy and market alternatives. In this case, aging is being framed as a health and pension problem to be solved, not as a market and policy innovation opportunity to be realized.

Perhaps it is the penchant of economists to rely on historic data that blinds them to a new opportunity hiding in plain sight. The older adults of today are profoundly different than those of previous generations. They are in better health, more active, and more ambitious about how they want to spend their “retirement” years. With these developments in mind, the shape of the “challenge” ahead of global policymakers and businesses ought to appear very different..

The G-20 decision-makers are correct that an aging population poses real challenges to businesses and policymakers alike — that is, if we continue to frame and address longer life as the same as it was decades, even centuries ago. But instead of portraying the growing number of older adults as a wave about to crash down on us, maybe governments and companies should start looking at it instead as an untapped opportunity — a new global longevity economy with endless possibilities and lifestyles yet to be envisioned.

One encouraging sign is that the framing the experts use changes depending on where you look. At the highest level, from the mouths of finance ministers and in international press releases, the vocabulary of risk and epidemic remains prominent. But go a little deeper, such as into the Global Coalition on Aging, the collaborative think tank that wrote the report driving G-20’s aging agenda, and you find talk about a global “opportunity”, “new possibilities,” a focus on “activity,“productivity,” andeven “happiness.” Those working closest to older adults recognize that the zeitgeist is changing. And even if the forum’s language isn’t up to speed, G-20’s “historic” attention to aging is both a sign of how far we’ve come and how much more is left to be done.

Source: Forbes

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.